CARDIOPURE
Dead / Cancelled — Cancelled — Section 8 (as of 04 Feb 2025)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87488179
- Registration number
- 5516872
- Mark type
- Stylized text
- Filed
- 14 Jun 2017
- Published for opposition
- 01 May 2018
- Registered
- 17 Jul 2018
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue for implantation into humans; biological tissue grafts; implants comprising living or biological tissue; replacement heart valves made of biological or living tissue
- Class 010 — Medical apparatus: Surgical implants intended for subsequent implantation namely, heart valves comprised primarily of artificial tissue and also incorporating processed animal or human tissue; medical devices and apparatus, namely, surgical implants comprised primarily of artificial tissue and also incorporating processed animal or human tissue for use in subsequent implantation
Owner
- Tissue Regenix Group Plc, Heslington, York, GB
- Tissue Regenix Group Plc, Heslington, York, GB
- Tissue Regenix Group Plc, Heslington, York, GB
Prosecution history
- 04 Feb 2025 — CANCELLED SEC. 8 (6-YR)
- 17 Jul 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Jun 2019 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 17 Jul 2018 — REGISTERED-PRINCIPAL REGISTER
- 01 May 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 May 2018 — PUBLISHED FOR OPPOSITION
- 11 Apr 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Mar 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Mar 2018 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Mar 2018 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Mar 2018 — ASSIGNED TO LIE
- 14 Mar 2018 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Sept 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Sept 2017 — NON-FINAL ACTION E-MAILED
- 14 Sept 2017 — NON-FINAL ACTION WRITTEN